Report

The Mexico biobanking market was valued at USD 1.10 Billion in 2024 and is expected to grow at a CAGR of 3.70% , reaching USD 1.58 Billion by 2034 . The market growth is driven by national genomic initiatives and advanced AI collaborations, enhancing personalized healthcare across the region.

Key Market Trends and Insights

- By type, equipment is expected to lead the market in the forecast period.
- Blood products accounted for 30% of the market share by sample type in the historical period.
- Pharmaceutical and biotechnological companies are anticipated to lead as primary end users of biobanking services.

Market Size and Forecast

- Market Size (2024): USD 1.10 Billion
- Projected Market Size (2034): USD 1.58 Billion
- CAGR (2025-2034): 3.70%

Mexico Biobanking Market Overview

The market is growing steadily, driven by national genomic initiatives and advanced collaborations integrating artificial intelligence. Efforts like the Mexican Biobank Project, which collects genetic data from diverse populations, are improving disease prevention and personalized medicine. These developments are also encouraging greater public participation, strengthening the research ecosystem further. Additionally, partnerships between local and international institutions boost innovation and research capabilities. Growing demand for biobanking services and cutting-edge technologies positions Mexico as an emerging hub for biobanking and life sciences research in the region.

Mexico Biobanking Market Growth Drivers

National Genomic Initiatives Fuel Growth in the Market

Significant push toward national-scale genetic research is expected to drive growth in the market. For instance, in January 2024, Disease Models & Mechanisms spotlighted the Mexican Biobank Project, which genotyped over 6,000 individuals from all 32 states. The project marks a vital step in building a comprehensive genetic reference for the country. This data provides valuable insights that can improve disease prevention and treatment strategies tailored to the Mexican population. It also fosters greater representation of diverse populations in scientific studies. As public awareness increases, more individuals may participate in biobanking efforts, further strengthening the research ecosystem.

Increasing Cutting Edge AI Collaborations Propelling the Mexico Biobanking Market Value

The integration of advanced technologies and collaborative research efforts is expected to be a strong growth driver in the market. For instance, in March 2025, United States and Mexican universities teamed up to combine artificial intelligence with Latin America's largest biobank to address Latino health disparities. This collaboration not only enhances data analysis but also accelerates precision medicine development tailored to diverse populations. Such initiatives significantly boost biobanking technology, positioning Mexico as a hub for innovative healthcare solutions and research partnerships.

Mexico Biobanking Market Trends

The market is witnessing several emerging trends, including international collaborations and AI-driven precision medicine advancements.

Rising International Partnerships Driving Innovation in the Market

Collaborations between leading institutions are becoming a key trend shaping the market. For instance, in November 2024, the Instituto Politecnico Nacional (IPN) and the University of Oxford partnered to establish a national biobank focused on colon cancer research. This collaboration aims to enhance understanding of the disease's genetic, cellular, and molecular characteristics in the Mexican population. By integrating international expertise and resources, the initiative is expected to accelerate diagnostic advancements and personalized treatment strategies, positioning Mexico as a leader in global biobanking efforts.

Mexico Biobanking Market Share

Blood Products to Lead the Market Segmentation by Sample Type

Blood products are expected to lead the segment due to their widespread use in diagnostics, transfusions, and therapeutic applications. The increasing focus on personalized medicine and improved healthcare infrastructure has further fueled the demand for blood-based samples. The growing prevalence of chronic diseases and the rising demand for blood-based tests have significantly driven market growth. Additionally, advancements in blood product processing and storage have improved efficiency, further boosting the segment's expansion. Other segments like human tissues, cell lines, nucleic acid, and human waste products also contribute in the market.

Leading Players in the Mexico Biobanking Market

The key features of the market report comprise funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:

Thermo Fisher Scientific Inc.

Founded in 1956 and headquartered in Waltham, Massachusetts, Thermo Fisher Scientific Inc. is a global leader in life sciences and laboratory equipment. The company offers a wide range of products, including reagents, instruments, and software that support research, diagnostics, and biopharmaceutical production. Its innovative solutions have greatly advanced scientific discovery and healthcare, making Thermo Fisher a key driver of growth and innovation in the life sciences industry. The company's strong focus on research and development continuously drives new product introductions. Its extensive global distribution network ensures broad accessibility to its cutting-edge technologies.

PHC Holdings Corporation

Established in 1936 and based in Tokyo, Japan, PHC Holdings Corporation specializes in medical and laboratory refrigeration solutions. The company is known for its advanced temperature-controlled storage systems that preserve biological samples and ensure sample integrity. PHC Holdings' dedication to quality and innovation has made it a major player in biobanking and clinical research, significantly contributing to the reliability and development of the life sciences sector. They also emphasize sustainable technologies to reduce environmental impact. Their strong customer service and tailored solutions enhance client trust and market presence.

Qiagen N.V.

Founded in 1984 and headquartered in Hilden, Germany, Qiagen N.V. focuses on sample and assay technologies essential for molecular diagnostics and research. The company provides high-quality tools for DNA, RNA, and protein analysis, supporting disease detection and personalized medicine. Qiagen's continuous innovation in molecular testing solutions has positioned it as a leader in academic and clinical laboratories, enhancing precision medicine worldwide. Strategic collaborations have further expanded their market reach and product capabilities. The company's commitment to regulatory compliance ensures trust across global healthcare markets.

Tecan Group Ltd.

Tecan Group Ltd. was founded in 1980 and is headquartered in Mannedorf, Switzerland. The company specializes in automated laboratory instruments that streamline workflows in genomics, proteomics, and diagnostics. Tecan's innovative automation platforms improve efficiency and accuracy in research and clinical testing. Its commitment to technological advancement has made Tecan a vital contributor to growth and progress in the life sciences industry. The company's adaptability helps labs meet evolving research demands and regulatory requirements. Ongoing investments in AI and robotics position Tecan for future innovation.

Other key players in the market include Becton, Dickinson and Company (BD), Merck KGaA, Avantor, Inc., Cryoport Inc., Azenta Inc., and Greiner AG.

Mexico Biobanking Market Segmentation

The market report offers a detailed analysis of the market based on the following segments:

Market Breakup by Type

- Equipment
??- Storage Equipment
??- Sample Analysis Equipment
??- Sample Processing Equipment
??- Sample Transport Equipment

- Consumables
??- Storage Consumables
??- Analysis Consumables
??- Processing Consumables
??- Collection Consumables

- Services
??- Storage Services
??- Processing Services
??- Transport Services
??- Supply Services

- Software

Market Breakup by Storage Type

- Manual Storage
- Automated Storage

Market Breakup by Sample Type

- Blood Products
- Human Tissues
- Cell Lines
- Nucleic Acid
- Human Waste Products
- Others

Market Breakup by Ownership

- Universities
- National/Regional Agencies
- Non-Profit Organizations
- Private Organizations

Market Breakup by Application

- Regenerative Medicine
- Life Science Research
- Clinical Research

Market Breakup by End User

- Pharmaceutical and Biotechnological Companies
- Hospital and Healthcare Providers
- Academic and Research Institutes
- Other End Users

Key Questions Answered in the Mexico Biobanking Market Report

- What was the Mexico biobanking market value in 2024?
- What is the Mexico biobanking market forecast outlook for 2025-2034?
- What is the market breakup based on type?
- What is the market segmentation based on storage type?
- What is the market segmentation based on sample type?
- What is the market segmentation based on ownership?
- What is the market segmentation based on application?
- What is the market breakup based on the end user?
- What are the major factors aiding the Mexico biobanking market demand?
- How has the market performed so far, and how is it anticipated to perform in the coming years?
- What are the market's major drivers, opportunities, and restraints?
- What are the major Mexico biobanking market trends?
- Which type is expected to dominate the market segment?
- Which storage type is projected to lead the market segment?
- Which sample type is likely to dominate the market segment?
- Which ownership is likely to dominate the market segment?
- Which application is likely to dominate the market segment?
- Which end user is likely to dominate the market segment
- Who are the key players involved in the Mexico biobanking market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?